10/30/2026 | Press release | Distributed by Public on 10/30/2026 03:11
Company: Sopharma AD (SFA3W)
Sopharma AD appointed a General Meeting of Warrantholders on 11 December 2026 at 11:00 am in Sofia, at 5 Lachezar Stanchev St., ground floor, Sopharma Business Towers Shopping Centre, Sopharma Event Centre, with the following agenda:
- Adoption of a report on the price movements of the company's ordinary shares on the regulated market over the last 12 months
- Adoption of a resolution for exercising the rights under the warrants of the issue with ISIN BG9200001253
- Request to the Board of Directors to pass a resolution for a conditional capital increase, provided that the holders of warrants of the issue with ISIN BG9200001253 exercise their rights and subscribe for shares from the capital increase
- In the absence of a quorum, the General Meeting of Warrantholders will be held on 18 December 2026 at 11:00 am - same place and agenda.
The right to vote at the General Meeting of Warrantholders will be entitled to all warrantholders registered with voting rights in the central securities register on the fourteenth (14th) day preceding the date of the meeting, i.e. as of 27 November 2026.
The final date for transacting warrants of this company on the Exchange, for warrantholders to be entitled to exercise their voting rights at the General Meeting of Warrantholders, will be 25 November 2026 (Ex Date: 26 November 2026).
The invitation is available on the website of the Exchange.
The entire notice is available in English on the financial website X3News